全文获取类型
收费全文 | 3224篇 |
免费 | 214篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 113篇 |
妇产科学 | 44篇 |
基础医学 | 489篇 |
口腔科学 | 74篇 |
临床医学 | 216篇 |
内科学 | 815篇 |
皮肤病学 | 93篇 |
神经病学 | 323篇 |
特种医学 | 87篇 |
外科学 | 358篇 |
综合类 | 9篇 |
预防医学 | 133篇 |
眼科学 | 91篇 |
药学 | 249篇 |
中国医学 | 8篇 |
肿瘤学 | 320篇 |
出版年
2024年 | 3篇 |
2023年 | 36篇 |
2022年 | 62篇 |
2021年 | 115篇 |
2020年 | 80篇 |
2019年 | 105篇 |
2018年 | 120篇 |
2017年 | 98篇 |
2016年 | 106篇 |
2015年 | 100篇 |
2014年 | 142篇 |
2013年 | 152篇 |
2012年 | 290篇 |
2011年 | 283篇 |
2010年 | 145篇 |
2009年 | 113篇 |
2008年 | 199篇 |
2007年 | 188篇 |
2006年 | 172篇 |
2005年 | 177篇 |
2004年 | 158篇 |
2003年 | 161篇 |
2002年 | 141篇 |
2001年 | 27篇 |
2000年 | 37篇 |
1999年 | 32篇 |
1998年 | 24篇 |
1997年 | 13篇 |
1996年 | 11篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 8篇 |
1992年 | 16篇 |
1991年 | 18篇 |
1990年 | 8篇 |
1989年 | 10篇 |
1988年 | 13篇 |
1987年 | 10篇 |
1986年 | 13篇 |
1983年 | 6篇 |
1978年 | 6篇 |
1976年 | 4篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1972年 | 2篇 |
1971年 | 3篇 |
1968年 | 2篇 |
1967年 | 2篇 |
1966年 | 5篇 |
1965年 | 6篇 |
排序方式: 共有3454条查询结果,搜索用时 0 毫秒
21.
Saheki T Kobayashi K Iijima M Horiuchi M Begum L Jalil MA Li MX Lu YB Ushikai M Tabata A Moriyama M Hsiao KJ Yang Y 《Molecular genetics and metabolism》2004,81(Z1):S20-S26
Citrin is a mitochondrial aspartate glutamate carrier primarily expressed in the liver, heart, and kidney. We found that adult-onset type II citrullinemia is caused by mutations in the SLC25A13 gene that encodes for citrin. In this report, we describe the frequency of SLC25A13 mutations, the roles of citrin as a member of the urea cycle and as a member of the malate-aspartate shuttle, the relationship between its functions and symptoms of citrin deficiency, and therapeutic issues. 相似文献
22.
23.
24.
Noriyuki Amano Kazumasa Matsumoto Yuriko Shimizu Marie Nakamura Hideyasu Tsumura Daisuke Ishii Yuichi Sato Masatsugu Iwamura 《Urologic oncology》2021,39(3):196.e1-196.e7
ObjectiveWe sought to identify heterogeneous nuclear ribonucleoprotein A3 (HNRNPA3) expression in bladder cancer and its relationship to clinicopathological findings and prognosis.MethodsImmunohistochemical staining for HNRNPA3 was performed on 122 archived radical cystectomy specimens, with immunoreactivity being stratified on a 0 to 3 scale. The percentage of HNRNPA3 expressing tumor cells was calculated and multiplied by the staining score over an average of 5 areas to obtain a semiquantitative H-score (maximum value: 300). HNRNPA3 expression was categorized as high (≥80) or low (<80).ResultsThe patients’ median age was 70 years, and the median follow-up period was 39.4 months. High HNRNPA3 expression was significantly associated with lymph node metastasis (P= 0.014) and S100A8, S100A9 and uroplakin III expression (P= 0.028, 0.002, and 0.047, respectively). Log-rank tests indicated that high HNRNPA3 expression was significantly associated with disease progression and cancer-specific death (P= 0.013 and 0.006, respectively). In the Cox proportional hazards regression analysis, only lymph node metastasis was associated with disease progression and cancer-specific survival.ConclusionHNRNPA3 may be a new biomarker to predict biologically aggressive cancers and determine the appropriate treatment modality in patients after radical cystectomy. 相似文献
25.
26.
Tsumura T Murata A Yamaguchi F Sugimoto K Hasegawa E Hatase O Nairn AC Tokuda M 《Vision research》1999,39(19):3165-3173
Ca2+/calmodulin-dependent protein kinase I (CaM-kinase I) in rat retina was analyzed by immunohistochemical analysis, Western blot analysis and kinase activity assay. Western blot analysis revealed two immunoreactive bands similar to those detected in the brain. Developmental studies revealed that CaM-kinase I expression increased in accordance with postnatal development. Expression of CaM-kinase I in the retinas of rats raised in the complete darkness markedly decreased. CaM-kinase I activity assay supported these findings. Synapsin I was shown to be a possible intrinsic substrate of CaM-kinase I in rat retina. These results elucidated that CaM-kinase I is expressed in the retina and may play an important role in the retinal functions and that the expression of CaM-kinase I is regulated by light stimulation. 相似文献
27.
Different roles of individual forms of human cytochrome P-450 (CYP) in the oxidation of 7-ethoxycoumarin and chlorzoxazone were investigated in liver microsomes of different human samples, and the microsomal activities thus obtained were predicted with kinetic parameters obtained from cDNA-derived recombinant CYP enzymes in microsomes of Trichoplusia ni cells. Of 14 forms of recombinant CYP examined, CYP1A1 had the highest activities (V(max)/K(m) ratio) in catalyzing 7-ethoxycoumarin O-deethylation followed by CYP1A2, 2E1, 2A6, and 2B6, although CYP1A1 has been shown to be an extrahepatic enzyme. With these kinetic parameters (excluding CYP1A1) we found that CYP1A2 and 2E1 were the major enzymes catalyzing 7-ethoxycoumarin; the contributions of these two forms were dependent on the contents of these CYPs in liver microsomes of different humans. Similarly, chlorzoxazone 6-hydroxylation activities of liver microsomes were predicted with kinetic parameters of recombinant human CYP enzymes and it was found that CYP3A4 as well as CYP1A2 and 2E1 were involved in chlorzoxazone hydroxylation, depending on the contents of these CYP forms in the livers. Recombinant CYP2A6 and 2B6 and CYP2D6 had considerable roles (V(max)/K(m) ratio) for 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation, respectively; however, these CYP forms had relatively minor roles in the reactions, probably due to low expression in human livers. These results support the view that the roles of individual CYP enzymes in the oxidation of xenobiotic chemicals in human liver microsomes could be predicted by kinetic parameters of individual CYP enzymes and by the levels of each of the CYP enzymes in liver microsomes of human samples. 相似文献
28.
A new fibular osteotomy in association with high tibial osteotomy (a comparative study with conventional mid-third fibular osteotomy) 总被引:2,自引:1,他引:1
A new technique for dividing the fibula when performing a high tibial osteotomy is described. The head of the fibula is enucleated
and morselized. The technique is simple and safe with a low complication rate.
Accepted: 17 March 2000 相似文献
Résumé En cas d’ostéotomie supérieure du tibia, nous décrivons une nouvelle technique d’ostéotomie péronière avec énucléation et morcellement de la tête du péroné. On peut employer pour ce faire la même incision cutanée que pour l’ostéotomie du tibia. L’incidence de complications est faible.
Accepted: 17 March 2000 相似文献
29.
A case of primary malignant lymphoma of the duodenum successfully treated with dose escalating chemotherapy 总被引:3,自引:0,他引:3
Oshiro A Nagasaki A Nakachi A Uchima N Hasegawa H Nakazato T Nakamoto M Kinjo N Kinjo F Taira N Masuda M Takasu N 《Gan to kagaku ryoho. Cancer & chemotherapy》2003,30(8):1169-1173
A 65-year-old woman with diabetes mellitus was hospitalized for heart failure and anemia in August 2001, and recovered with conservative treatment. An endoscopic examination revealed an ulcerative mass located in the duodenal bulb to the 2nd portion. Abdominal CT scan demonstrated tumor involvement in the pancreas head. The diagnosis of a diffuse large B-cell lymphoma, clinical stage IIE, was made by endoscopic biopsy. Although surgical resection of the localized intestinal tumor would have been a common choice for initial treatment, polychemotherapy was selected; the patient had diabetes mellitus and preferred polychemotherapy to surgical operation. Because of bulky intestinal mass, transmural disease and sensitive histological type, standard-dose chemotherapy was considered to include a high risk of intestinal perforation. We performed dose-escalating chemotherapy: A half dose of THP-COP (pirarubicin, cyclophosphamide, vincristine) was given at the start in October 2001, 60% THP-COP as the next cycle, 80% THP-COP as the 3rd cycle and thereafter. Without serious complications of the intestine, she received a total of 6 cycles of chemotherapy and subsequent involved field radiation. There has been no evidence of recurrence of disease 14 months from the start of chemotherapy. When conditions make surgical treatment difficult, dose-escalating chemotherapy in a treatment cycle may be considered as an alternative. 相似文献
30.
Takafumi Mizuno Takao Hoshino Kentaro Ishizuka Sono Toi Ayako Nishimura Shuntaro Takahashi Sho Wako Kazuo Kitagawa 《Journal of atherosclerosis and thrombosis》2022,29(9):1393
Aims: We aimed to determine the characteristics and vascular outcomes of stroke in renal transplant (RT) recipients and compare them with those in patients on hemodialysis (HD) and those with no renal replacement therapy (RRT). Methods: In this prospective observational study, 717 patients (mean age, 70.8 years; male, 60.5%) with acute ischemic stroke within one week of onset were consecutively enrolled and followed for one year. The patients were classified into three groups: (1) living donor RT recipients (n=27); (2) patients on maintenance HD before the index stroke (n=39); and (3) those with no history of RRT (n=651). The primary outcome was a composite of major adverse cardiovascular events (MACE). Results: Diabetic nephropathy was the most common reason for RRT in both RT and HD patients. RT patients were more likely to have embolic stroke of undetermined source (33.3%) than others, whereas HD patients more often had cardioembolism (51.3%). No difference was observed in the MACE risk between the patients in RT and non-RRT groups (annual rate, 11.3% vs. 13.1%; log-rankP=0.82; hazard ratio [95% confidence interval], 0.92 [0.29-2.98]). In contrast, HD patients had a greater risk of MACE than those with no RRT (annual rate, 28.2% vs. 13.1%; log-rankP=0.019; hazard ratio [95% confidence interval], 2.24 [1.16-4.3]). Conclusions: The underlying etiologies of stroke differed in RT and HD patients. The one-year risk of MACE for stroke patients who had received an RT was lower than that for patients undergoing HD and comparable with that of patients with no RRT. 相似文献